Bernstein Remains a Buy on Akeso, Inc. (9926)
Akeso, Inc.: Sustained Profitability and Promising Pipeline Secure a Buy Rating
Nomura Adjusts Akeso's Price Target to HK$46.04 From HK$52.80, Keeps at Buy
Analysts' Opinions Are Mixed on These Healthcare Stocks: Carl Zeiss Meditec (GB:0DHC), Akeso, Inc. (HK:9926) and Almirall (GB:0O9B)
Nomura Adjusts Akeso's Price Target to HK$52.80 From HK$48.84, Keeps at Buy
Nomura Adjusts Akeso's Price Target to HK$50.14 From HK$46.04, Keeps at Buy
Nomura Adjusts Akeso's Price Target to HK$31.54 From HK$35.81, Keeps at Buy
UBS Adjusts Akeso’s Price Target to HK$26.68 From HK$29.60, Keeps at Buy
No Data